KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CareDx (CDNA) EBITDA Margin (2016 - 2025)

CareDx (CDNA) has disclosed EBITDA Margin for 13 consecutive years, with 5.57% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin fell 10303.0% to 5.57% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 8.1% through Dec 2025, down 2032.0% year-over-year, with the annual reading at 8.1% for FY2025, 2032.0% down from the prior year.
  • EBITDA Margin hit 5.57% in Q4 2025 for CareDx, down from 0.25% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 97.46% in Q4 2024 to a low of 187.03% in Q4 2023.
  • Historically, EBITDA Margin has averaged 21.4% across 5 years, with a median of 18.0% in 2021.
  • Biggest five-year swings in EBITDA Margin: crashed -16382bps in 2023 and later surged 28449bps in 2024.
  • Year by year, EBITDA Margin stood at 19.44% in 2021, then decreased by -19bps to 23.21% in 2022, then plummeted by -706bps to 187.03% in 2023, then soared by 152bps to 97.46% in 2024, then tumbled by -106bps to 5.57% in 2025.
  • Business Quant data shows EBITDA Margin for CDNA at 5.57% in Q4 2025, 0.25% in Q3 2025, and 12.83% in Q2 2025.